Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Immunology
Volume 2017, Article ID 2676403, 9 pages
https://doi.org/10.1155/2017/2676403
Case Report

Necrotizing Liver Granuloma/Abscess and Constrictive Aspergillosis Pericarditis with Central Nervous System Involvement: Different Remarkable Phenotypes in Different Chronic Granulomatous Disease Genotypes

1Pediatric Immunology Department, Medical Faculty, Ege University, Izmir, Turkey
2Interventional Radiology Department, Medical Faculty, Ege University, Izmir, Turkey
3Cardiovascular Surgery Department, Medical Faculty, Ege University, Izmir, Turkey
4Pediatric Cardiology Department, Medical Faculty, Ege University, Izmir, Turkey
5Pediatric Intensive Care Unit, Medical Faculty, Ege University, Izmir, Turkey
6Pediatric Surgery Department, Medical Faculty, Ege University, Izmir, Turkey
7Radiology Department, Medical Faculty, Ege University, Izmir, Turkey
8Pediatric Radiology Department, Medical Faculty, Ege University, Izmir, Turkey

Correspondence should be addressed to Sanem Eren Akarcan; moc.oohay@nerenas

Received 1 November 2016; Accepted 21 December 2016; Published 10 January 2017

Academic Editor: Anne E. Tebo

Copyright © 2017 Sanem Eren Akarcan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. B. Kuhns, W. G. Alvord, T. Heller et al., “Residual NADPH oxidase and survival in chronic granulomatous disease,” The New England Journal of Medicine, vol. 363, no. 27, pp. 2600–2610, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. J. A. Winkelstein, M. C. Marino, R. B. Johnston Jr. et al., “Chronic granulomatous disease. Report on a national registry of 368 patients,” Medicine, vol. 79, no. 3, pp. 155–169, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. J. M. van den Berg, E. van Koppen, A. Åhlin et al., “Chronic granulomatous disease: the european experience,” PLoS ONE, vol. 4, Article ID e5234, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. B. E. Marciano, C. Spalding, A. Fitzgerald et al., “Common severe infections in chronic granulomatous disease,” Clinical Infectious Diseases, vol. 60, no. 8, pp. 1176–1183, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. D. Roos, D. B. Kuhns, A. Maddalena et al., “Hematologically important mutations: X-linked chronic granulomatous disease (third update),” Blood Cells, Molecules, and Diseases, vol. 45, no. 3, pp. 246–265, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. D. Roos, D. B. Kuhns, A. Maddalena et al., “Hematologically important mutations: the autosomal recessive forms of chronic granulomatous disease (second update),” Blood Cells, Molecules, and Diseases, vol. 44, no. 4, pp. 291–299, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. F. Fattahi, M. Badalzadeh, L. Sedighipour et al., “Inheritance pattern and clinical aspects of 93 Iranian patients with chronic granulomatous disease,” Journal of Clinical Immunology, vol. 31, no. 5, pp. 792–801, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Y. Köker, Y. Camcıoğlu, K. van Leeuwen et al., “Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 Turkish patients,” The Journal of Allergy and Clinical Immunology, vol. 132, no. 5, pp. 1156–1163.e5, 2013. View at Publisher · View at Google Scholar
  9. B. Martire, R. Rondelli, A. Soresina et al., “Clinical features, long-term follow-up and outcome of a large cohort of patients with Chronic Granulomatous Disease: an Italian multicenter study,” Clinical Immunology, vol. 126, no. 2, pp. 155–164, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. S. A. Mahdaviani, S. A. Mohajerani, N. Rezaei, J.-L. Casanova, S. D. Mansouri, and A. A. Velayati, “Pulmonary manifestations of chronic granulomatous disease,” Expert Review of Clinical Immunology, vol. 9, no. 2, pp. 153–160, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. F. Conti, S. O. Lugo-Reyes, L. Blancas Galicia et al., “Mycobacterial disease in patients with chronic granulomatous disease: a retrospective analysis of 71 cases,” American Academy of Allergy Asthma and Immunology, vol. 138, no. 1, pp. 241–248, 2016. View at Publisher · View at Google Scholar
  12. M. A. Yamazaki-Nakashimada, E. R. Stiehm, D. Pietropaolo-Cienfuegos, V. Hernandez-Bautista, and F. Espinosa-Rosales, “Corticosteroid therapy for refractory infections in chronic granulomatous disease: case reports and review of the literature,” Annals of Allergy, Asthma and Immunology, vol. 97, no. 2, pp. 257–261, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Beauté, G. Obenga, L. Le Mignot et al., “Epidemiology and Outcome of invasive fungal diseases in patients with chronic granulomatous disease: a multicenter study in France,” Pediatric Infectious Disease Journal, vol. 30, no. 1, pp. 57–62, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Blumental, R. Mouy, N. Mahlaoui et al., “Invasive mold infections in chronic granulomatous disease: a 25-year retrospective survey,” Clinical Infectious Diseases, vol. 53, no. 12, pp. e159–e169, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. E. L. Falcone and S. M. Holland, “Invasive fungal infection in chronic granulomatous disease: insights into pathogenesis and management,” Current Opinion in Infectious Diseases, vol. 25, no. 6, pp. 658–669, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. T. J. Walsh and B. H. Bulkley, “Aspergillus pericarditis: clinical and pathologic features in the immunocompromised patient,” Cancer, vol. 49, no. 1, pp. 48–54, 1982. View at Publisher · View at Google Scholar · View at Scopus
  17. V. Le Moing, O. Lortholary, J.-F. Timsit et al., “Aspergillus pericarditis with tamponade: report of a successfully treated case and review,” Clinical Infectious Diseases, vol. 26, no. 2, pp. 451–460, 1998. View at Publisher · View at Google Scholar · View at Scopus
  18. K. L. Mortensen, J. B. Knudsen, S. Jensen-Fangel, B. Stausbøl-Grøn, M. C. Arendrup, and E. Petersen, “Successful management of invasive aspergillosis presenting as pericarditis in an adult patient with chronic granulomatous disease,” Mycoses, vol. 54, no. 4, pp. e233–e236, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. B. De Pauw, T. J. Walsh, J. P. Donnelly et al., “Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group,” Clinical Infectious Diseases, vol. 46, no. 12, pp. 1813–1821, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. E. M. Kang, B. E. Marciano, S. Deravin, K. A. Zarember, S. M. Holland, and H. L. Malech, “Chronic granulomatous disease: overview and hematopoietic stem cell transplantation,” Journal of Allergy and Clinical Immunology, vol. 127, no. 6, pp. 1319–1326, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. B. Bielorai, A. Toren, B. Wolach et al., “Successful treatment of invasive aspergillosis in chronic granulomatous disease by granulocyte transfusions followed by peripheral blood stem cell transplantation,” Bone Marrow Transplantation, vol. 26, no. 9, pp. 1025–1028, 2000. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Ikincioğullari, F. Dogu, N. Solaz et al., “Granulocyte transfusions in children with chronic granulomatous disease and invasive Aspergillosis,” Therapeutic Apheresis and Dialysis, vol. 9, no. 2, pp. 137–141, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. D. P. Borge, R. DeCastro, N. Theobald, H. Malech, S. Leitman, and E. M. Kang, “Successful Control of preexistent active infection by granulocyte transfusions during conditioning induced cytopenia in patients with chronic granulomatous disease undergoing hematopoietic stem cell transplant,” Blood, vol. 116, no. 21, p. 1329, 2010. View at Publisher · View at Google Scholar
  24. T. K. Kourkoumpetis, A. Desalermos, M. Muhammed, and E. Mylonakis, “Central nervous system aspergillosis: a series of 14 cases from a general hospital and review of 123 cases from the literatur,” Medicine, vol. 91, no. 6, pp. 328–336, 2012. View at Publisher · View at Google Scholar
  25. J. R. Ellenbogen, M. Waqar, R. P. D. Cooke, and M. Javadpour, “Management of granulomatous cerebral aspergillosis in immunocompetent adult patients: a review,” British Journal of Neurosurgery, vol. 30, no. 3, pp. 280–285, 2016. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Alsultan, M. S. Williams, S. Lubner, and F. D. Goldman, “Chronic granulomatous disease presenting with disseminated intracranial aspergillosis,” Pediatric Blood & Cancer, vol. 47, no. 1, pp. 107–110, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. N. Hussain, J. J. Feld, D. E. Kleiner et al., “Hepatic abnormalities in patients with chronic granulomatous disease,” Hepatology, vol. 45, no. 3, pp. 675–683, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Lublin, D. L. Bartlett, D. N. Danforth et al., “Hepatic abscess in patients with chronic granulomatous disease,” Annals of Surgery, vol. 235, no. 3, pp. 383–391, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Chiriaco, I. Salfa, G. Di Matteo, P. Rossi, and A. Finocchi, “Chronic granulomatous disease: clinical, molecular, and therapeutic aspects,” Pediatric Allergy and Immunology, vol. 27, no. 3, pp. 242–253, 2016. View at Publisher · View at Google Scholar · View at Scopus